Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Fluvoxamine Maleate Extended-Release Capsules Articles

Solvay's 1st-qtr 2008 net income rises 1%

26 May 2008

Jazz' net loss deepens to $46.7M in 1st qtr

26 May 2008

FDA approves Luvox ER for anxiety and OCD

10 March 2008

Jazz' Luvox PDUFA set for Feb 29

11 February 2008

FDA "approvable" letters for dalbavancin, Luvox CR and bazedoxifene

7 January 2008

FDA accepts Solvay response for Luvox NDA; Jazz hopes to launch in 1st-qtr 2008

13 August 2007

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS